Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 4/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.50 |
| ▸ | CA2 | P00918 | 8/20 | 0.48 |
| ▸ | CA9 | Q16790 | 7/20 | 0.48 |
| ▸ | CA1 | P00915 | 6/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6799582 | 0.74 | STS (0.63) | STSCA2CA9CA1CA12 | |
| SCHEMBL6799239 | 0.72 | STS (0.61) | STSCA2CA9CA1CA12 | |
| SCHEMBL2501211 | 0.70 | STS (1.00) | STSCA2CA9CA1CA12 | |
| SCHEMBL6796502 | 0.70 | CYP2C19 (0.53) | CYP19A1POLB | |
| SCHEMBL27878193 | 0.69 | CYP2C19 (0.56) | — | |
| SCHEMBL7454758 | 0.69 | CA2 (0.58) | STSCYP19A1CA2CA9CA1 | |
| SCHEMBL6801523 | 0.67 | CA2 (0.66) | STSCA2CA9CA1CA12 | |
| SCHEMBL3240934 | 0.66 | CYP19A1 (0.71) | STSCYP19A1CA2 | |
| SCHEMBL6797084 | 0.64 | CA1 (0.67) | STSCYP19A1CA2CA9CA1 | |
| SCHEMBL5871758 | 0.64 | STS (0.81) | STSCA2CA9CA1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6762205-B1 | STEROID SULFATASE INHIBITORS WITHOUT ESTROGENIC SIDE EFFECT ACTION | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 2004-07-13 | — | — | US | disclosed |
| EP-1193250-A1 | PHENYL SULFAMATE DERIVATIVES | Teikoku Hormone Mfg. Co., Ltd. (JP) | 2002-04-03 | — | — | EP | disclosed |